U.S. Physical Therapy, Inc. (USPH) To Go Ex-Dividend on November 15th

U.S. Physical Therapy, Inc. (NYSE:USPH) announced a dividend on Thursday, November 7th, Fidelity reports. Stockholders of record on Monday, November 18th will be given a dividend of 0.30 per share on Friday, December 13th. The ex-dividend date of this dividend is Friday, November 15th.

USPH stock opened at $117.50 on Friday. The company’s 50 day simple moving average is $134.71 and its 200-day simple moving average is $126.55. The firm has a market capitalization of $1.86 billion, a PE ratio of 44.34, a P/E/G ratio of 4.05 and a beta of 1.09. U.S. Physical Therapy has a 12 month low of $98.69 and a 12 month high of $148.48. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.88 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.71 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.71. The business had revenue of $117.30 million for the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.64 earnings per share. As a group, sell-side analysts anticipate that U.S. Physical Therapy will post 2.94 earnings per share for the current year.

In other news, CEO Christopher J. Reading sold 601 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $135.39, for a total value of $81,369.39. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Mark J. Brookner sold 3,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $134.84, for a total transaction of $404,520.00. The disclosure for this sale can be found here. Insiders have sold a total of 20,303 shares of company stock worth $2,739,080 over the last 90 days. 2.50% of the stock is owned by insiders.

A number of equities analysts have weighed in on the stock. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price target on the stock in a research note on Friday. ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. Finally, Zacks Investment Research restated a “hold” rating on shares of U.S. Physical Therapy in a research report on Saturday, October 19th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $127.20.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: What is the price-to-earnings growth (PEG) ratio?

Dividend History for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.